InvestorsHub Logo
Followers 45
Posts 5073
Boards Moderated 0
Alias Born 01/27/2012

Re: jmvho post# 213875

Thursday, 10/10/2019 11:06:19 AM

Thursday, October 10, 2019 11:06:19 AM

Post# of 456860

I was just pointing out what the dollars could be to shareholders if Anavex were to just sell off the rights to one indication.



Good point Jmvho, buyout precedence being displayed here again. At first, 2.5 billion is scary but when you put the entire “string of inestimable pearls” of ODD disease at a price of $40/1.5 billion each and then that helps me rest easier.
So we “should” climb to about 1 billion/$30ish in MC for Rett approval, multiples of 5 x that/$100-$150ish for Parkinsons (with data confirming/supporti g allowing approval) and all this right before the mother load... HOLYGRAIL news release of a partnership for Alzheimer’s......with approval being the #1 requirement.

Bravo Dr Missling!! Imo this is a very likely plan by Missling and the BOD. How else could you prevent a takeover after approval for Rett and or Parkinsons except to BLOW onto the scene with a CNS “flashover” moment so bright it would be like staring at the sun or even better yet like witnessing a nuclear bomb going off in the distance.

Lets nuke em!!!!!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News